Effect of immunosuppressants on inflammatory bowel disease: tacrolimus and cyclosporine
Nakase, H.; Matsuura, M.; Chiba, T.
Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 1): 324-328
2012
ISSN/ISBN: 0047-1852 PMID: 23126111 Document Number: 659853
Document emailed within 1 workday
Related Documents
Thorp, M.; DeMattos, A.; Bennett, W.; Barry, J.; Norman, D. 2000: The effect of conversion from cyclosporine to tacrolimus on gingival hyperplasia, hirsutism and cholesterol Transplantation 69(6): 1218-1220Chen, H.; Peng, J.; Luo, H.; Loubeau, M.; Wan, X.; Xu, D.; Qi, S.; Vu, M.D.; Daloze, P.; Fitzsimmons, W.E.; Bekersky, I.; Peets, J.; Sehgal, S.N.; Wu, J. 2000: Compromised kidney graft rejection response in Vervet monkeys after withdrawal of immunosuppressants tacrolimus and sirolimus Transplantation 69(8): 1555-1561
Weiss, D.J.; Gagne, J.M.; Armstrong, P.J. 1996: Relationship between inflammatory hepatic disease and inflammatory bowel disease, pancreatitis, and nephritis in cats Journal of the American Veterinary Medical Association 209(6): 1114-1116
Prakash, O.; Medhi, B.; Saikia, U.N.; Pandhi, P. 2011: Effect of combination of thalidomide and sulfasalazine in experimentally induced inflammatory bowel disease in rats Indian Journal of Experimental Biology 49(9): 672-678
Silberer, H.; Küppers, B.; Mickisch, O.; Baniewicz, W.; Drescher, M.; Traber, L.; Kempf, A.; Schmidt-Gayk, H. 2005: Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome Clinical Laboratory 51(3-4): 117-126
Walker, E.A.; Katon, W.J.; Roy-Byrne, P.P.; Jemelka, R.P.; Russo, J. 1993: Histories of sexual victimization in patients with irritable bowel syndrome or inflammatory bowel disease American Journal of Psychiatry 150(10): 1502-1506
Jagtap, A.G.; Niphadkar, P.V.; Phadke, A.S. 2011: Protective effect of aqueous extract of Bombax malabaricum DC on experimental models of inflammatory bowel disease in rats and mice Indian Journal of Experimental Biology 49(5): 343-351
Geboes, K.; Desreumaux, P.; Jouret, A.; Ectors, N.; Rutgeerts, P.; Colombel, J.F. 1999: Histopathologic diagnosis of the activity of chronic inflammatory bowel disease. Evaluation of the effect of drug treatment. use of histological scores Gastroenterologie Clinique et Biologique 23(10): 1062-1073
Brullet, E.; Bonfill, X.; Urrútia, G.; Ruiz Ochoa, V.; Cueto, M.; Clofent, J.; Martínez Salmerón, J.F.; Riera, J.; Obrador, A. 1998: Epidemiological study on the incidence of inflammatory bowel disease in 4 Spanish areas. Spanish Group on the Epidemiological Study of Inflammatory Bowel Disease Medicina Clinica 110(17): 651-656
Veljaca, M. 2001: Anti-inflammatory peptides and proteins in inflammatory bowel disease Current Opinion in Investigational Drugs 2(10): 1387-1394
Toledo-Pereyra, L.H.; Kaufmann, R.J.; Bergren, C.T. 1987: Effect of cyclosporine on fresh and preserved orthotopic small bowel allografts Puerto Rico Health Sciences Journal 6(3): 147-152
Kirsner, J.B. 1999: "Nonspecific" inflammatory bowel disease (ulcerative colitis and Crohn's disease) after 100 years--what next? Italian Journal of Gastroenterology and Hepatology 31(8): 651-658
Akolkar, P.N.; Gulwani-Akolkar, B.; Heresbach, D.; Lin, X.Y.; Fisher, S.; Katz, S.; Silver, J. 1997: Differences in risk of Crohn's disease in offspring of mothers and fathers with inflammatory bowel disease American Journal of Gastroenterology 92(12): 2241-2244
Becker, K.; Niederau, C.; Frieling, T. 1999: Fecal excretion of alpha 2-macroglobulin: a novel marker for disease activity in patients with inflammatory bowel disease Zeitschrift für Gastroenterologie 37(7): 597-605
Krawiec, P.; Pawłowska-Kamieniak, A.; Pac-Kożuchowska, E.żb.; Mroczkowska-Juchkiewcz, A.; Kominek, K. 2016: Coexistence of coeliac disease and inflammatory bowel disease in children Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 40(235): 53-55
Mesar, I.; Basić-Jukić, N.; Bubić-Filipi, L.; Kastelan, Z.; Bacak-Kocman, I.; Kes, P. 2011: Outcome of renal transplantation after tacrolimus switch to cyclosporine Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 65(4): 311-314
García López, S. 2008: Inflammatory bowel disease. If a patient with Crohn's disease remains in remission for 4 years with azathioprine (or mercaptopurine), should the drug be withdrawn? Gastroenterologia y Hepatologia 31(10): 704-705
Kmieć, Z. 1998: Cytokines in inflammatory bowel disease Archivum Immunologiae et Therapiae Experimentalis 46(3): 143-155
Kollerová, J.; Koller, T.áš; Hlavatý, T.; Payer, J. 2015: Hormonal changes in inflammatory bowel disease Vnitrni Lekarstvi 61(12 Suppl 5: 5s35-5s39
Manser, W.W. 1990: Management of inflammatory bowel disease JPMA. Journal of the Pakistan Medical Association 40(11): 279